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DNA Repair Gene X-Ray Repair Cross Complementing
Group 1 Arg194Trp Polymorphism on the Risk of
Lung Cancer
A Meta-Analysis on 22 Studies
Jingwei Jiang, MD, Xiaohua Liang, MD, Xinli Zhou, MD, Ruofan Huang, MD, Zhaohui Chu, MD,
Qiong Zhan, MD, and Hao Lin, MD
Background: DNA repair gene X-ray repair cross complementing
group 1 (XRCC1) Arg194Trp polymorphism has been investigated
widely on lung cancer risk. However, the results are inconclusive.
To derive a more precise estimation of the relationship between
XRCC1 Arg194Trp polymorphism and lung cancer risk, we per-
formed this meta-analysis.
Methods: An electronic search of the database PubMed, Embase,
and Chinese National Knowledge Infrastructure was performed. The
odds ratio (OR) was pooled by STATA 10.1. Subgroup analyses by
ethnicity, gender, smoking, and histologic types of lung cancer were
performed.
Results: Twenty-two studies including 7515 cases and 9560 con-
trols were identified ultimately. The pooled OR for total population
showed that homozygous Trp/Trp variant genotype could increase
lung cancer risk compared with the homozygous wild Arg/Arg
genotype (OR  1.22, 95% confidence interval [CI]  1.04–1.44,
p  0.01); however, heterozygote Arg/Trp variant genotype could
decrease lung cancer risk (OR  0.91, 95% CI  0.85–0.99, p 
0.02). Subgroup analyses by ethnicity confirmed the result that
homozygous Trp/Trp variant genotype increased lung cancer risk in
Asians (OR  1.19, 95% CI  1.01–1.41, p  0.04) but not in
whites. It was interesting to find that both the heterozygote Arg/Trp
and the combined Trp/Trp  Arg/Trp variant genotypes could
decrease the risk of lung cancer in whites (OR  0.83, 95% CI 
0.72–0.96, p  0.01; OR  0.85, 95% CI  0.74–0.98, p  0.03,
respectively) but not in Asians. Subgroup analyses by gender,
smoking, and histologic types of lung cancer did not indicate any
significant difference between cases and controls, excepted for male
population, which carried heterozygote Arg/Trp variant genotype
that could decrease lung cancer risk (OR  0.54, 95% CI 
0.31–0.95, p  0.03).
Conclusions: Homozygous Trp/Trp variant genotype of XRCC1
Arg194Trp polymorphism could increase lung cancer risk in total
population, especially in Asians. However, the heterozygote Arg/
Trp variant genotype might decrease the risk of lung cancer, espe-
cially in whites.
Key Words: Lung neoplasms, Genetic predisposition to disease, DNA-
binding proteins, Polymorphism, Single nucleotide, Meta-analysis.
(J Thorac Oncol. 2010;5: 1741–1747)
Lung cancer is the most common cancer in the world. In2002, there were 1.35 million new cases, representing
12.4% of total cancers. It was also the leading cause of death
from cancer, with 1.18 million global deaths, representing
17.6% of the total deaths from cancer.1 DNA repair systems
play a critical role in protecting the genome from insults
caused by carcinogenic agents, such as those found in to-
bacco smoke.2 X-ray repair cross complementing group 1
(XRCC1) is one of the major DNA repair proteins involved
in the base-excision repair pathway, and Arg194Trp poly-
morphism (C to T substitution at position 26304 of exon 6
resulting in an amino acid change Arg194Trp) was one of the
most extensively studied single-nucleotide polymorphisms of
XRCC1 gene.3 The frequencies of variant allele in codon 194
among Asians, whites, and Africans were 31.2%, 6.6%, and
7.3%, respectively.4 Epidemiology studies on the association
between XRCC1 Arg194Trp polymorphism and lung cancer
risk have given inconsistent results, partially because of the
possible small effect of the XRCC1 Arg194Trp polymor-
phism on the risk of lung cancer and the relatively small
sample size in each of published studies. Therefore, a meta-
analysis is needed to pool the data. In 2006, Kiyohara et al.5
performed a meta-analysis on eight studies and did not find a
relationship between the Arg194Trp polymorphism and the
risk of lung cancer. In 2009, Zheng et al.6 performed a
meta-analysis in Chinese population on six studies and also
did not find a relationship between the combined Arg/Trp and
Trp/Trp variant genotypes and lung cancer risk (odds ratio
[OR]  1.06, 95% confidence interval [CI]  0.89–1.27).
However, Wang et al.7 found that XRCC1 codon 194 hetero-
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zygote Arg/Trp genotype could decrease lung cancer risk
(OR  0.88, 95% CI  0.79–0.97) in a meta-analysis using
4848 cases and 6592 controls from 16 studies. The results of
these meta-analyses were also inconsistent, and there are
many studies not included in the meta-analyses of Kiyohara
et al.5 and Wang et al.,7 and the meta-analysis of Zheng et al.6
only included Chinese population; neither of the three meta-
analyses performed subgroup analyses by gender, smoking,
and histologic types of lung cancer. We conducted a com-
prehensive meta-analysis of the largest group of studies to
date to investigate the possible relationship between XRCC1
Arg194Trp polymorphism and the risk of lung cancer. Sub-
group analyses by ethnicity, gender, smoking, and histologic
types of lung cancer were performed.
METHODS
Search Strategy and Study Selection
An electronic search of the database PubMed, Embase,
and Chinese National Knowledge Infrastructure was per-
formed. The last search was updated in March 2010. The
following keywords were used: “Lung Neoplasms,” “lung
cancer,” “x-ray repair cross complementing group 1,”
“XRCC1,” and “DNA repair gene.” The published languages
and years were not limited. Reference lists of original articles
and review articles were also examined for additional studies.
Case-control studies were eligible if they reported the rela-
tionship between XRCC1 Arg194Trp polymorphism and the
risk of lung cancer. When the same authors reported results
obtained from the same patient population in more than one
publication, only the most complete one was included in the
analysis. Two reviewers (J.J. and H.L.) independently deter-
mined study eligibility. Disagreements were resolved by
consensus.
Data Abstraction
All the data were independently abstracted by two
investigators (J.J. and H.L.) with the use of standardized
data-abstraction forms. Disagreements were resolved by dis-
cussion with an independent expert (X.L.). The following
information were sought from each article, although some
articles did not contain all the information: first authors, years
of publication, published languages, ethnicities and countries
of the cases and controls, gender, smoking status, source of
controls, sample size, matching criteria, and numbers of
genotype Trp/Trp, Arg/Trp, Trp/Trp Arg/Trp, and Arg/Arg
for both cases and controls.
Statistical Analysis
The ORs were aggregated using STATA 10.1 package.
A statistical test with a p value less than 0.05 was considered
significant. OR 1 reflects XRCC1 Arg194Trp polymor-
phism increase the risk of lung cancer and vice versa. To
investigate the statistical heterogeneity between trials, the
standard 2 Q-test was applied (meaningful differences be-
tween studies indicated by p  0.10). If fine homogeneity
was found, a fixed-effect model was used for analysis; if not,
a random-effect model was used. All p values were two sided.
All CIs had a two-sided probability coverage of 95%. Evi-
dence of publication bias was sought using the methods of
Egger et al.8 and Begg and Mazumdar.9
RESULTS
Trial Flow
One hundred and seven studies were retrieved origi-
nally after preliminary searching, and 23 studies10–32 were
identified after scanning the titles and abstracts. One study32
was excluded for the same author reported results obtained
from the same patient population in another publication.30
Characteristics of the 22 Studies
Twenty-two studies10–31 including 7515 cases and 9560
controls were identified ultimately. All the 22 studies were
published in full texts. Baseline characteristics of the 22
studies were listed in Table 1. Four studies11,17,22,28 were
published in Chinese and the other 17 studies were published
in English. One study17 chose the cases with squamous cell
carcinoma, one18 with non-small cell lung cancer, and the
others chose the cases with all histologic types of lung cancer.
XRCC1 Arg194Trp Polymorphism on Lung
Cancer Risk in Total Population
All the 22 studies reported numbers of genotypes Gln/
Gln, Arg/Gln, Gln/Gln  Arg/Gln, and Arg/Arg for both
cases and controls (Table 2).
The pooled ORs for total population showed that ho-
mozygous Trp/Trp variant genotype could increase lung can-
cer risk compared with the homozygous wild Arg/Arg geno-
type (OR  1.22, 95% CI  1.04–1.44, p  0.01; Figure 1);
however, heterozygote Arg/Trp variant genotype could de-
crease lung cancer risk (OR  0.91, 95%  0.85–0.99, p 
0.02; Figure 2). There was no significant association between
the combined Trp/Trp  Arg/Trp variant genotypes and lung
cancer risk (OR  0.95, 95% CI  0.88–1.02; Figure 3).
There were not significant heterogeneities (0.11, 0.49, and
0.12 for Trp/Trp versus Arg/Arg, Arg/Trp versus Arg/Arg,
and Trp/Trp  Arg/Trp versus Arg/Arg, respectively), and
the pooled ORs were performed using fixed-effect model
(Table 3).
XRCC1 Arg194Trp Polymorphism on Lung
Cancer Risk in Specific Population
The results of subgroup analyses by ethnicity, gender,
and smoking were shown in Table 3.
There were 14 studies10–12,14,15,17,21–23,26–30 reported
XRCC1 Arg194Trp polymorphism on lung cancer risk in
Asians, six studies13,16,18,20,24,25 in whites, and two studies19,31
in a mixed population. The subgroup analyses by ethnicity
also showed homozygous Trp/Trp variant genotype increased
lung cancer risk in Asians (OR  1.19, 95% CI  1.01–1.41,
p  0.04) but not in whites (OR  1.43, 95% CI 
0.79–2.59, p  0.24). It was interesting to find that both the
heterozygote Arg/Trp and the combined Trp/Trp  Arg/Trp
variant genotypes could decrease the risk of lung cancer in
whites but not in Asians (Table 3, Figures 2 and 3).
There were only two studies13,27 reported data on
XRCC1 Arg194Trp polymorphism on lung cancer risk in
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TABLE 2. Genotypes Distribution of XRCC1 Arg194Trp Polymorphism in Cases and Controls of Individual Studies Eligible for
the Meta-Analysis
Authors
No. of Cases No. of Controls
Arg/Arg Arg/Trp Trp/Trp Trp/TrpArg/Trp Arg/Arg Arg/Trp Trp/Trp Trp/TrpArg/Trp
Yin et al.10 29 21 1 22 28 38 8 46
Su et al.11 208 137 51 188 263 165 37 202
Li et al.12 184 136 30 166 196 133 21 154
Improta et al.13 78 9 7 16 104 17 0 17
Yin et al.14 120 98 23 121 119 109 21 130
Pachouri et al.15 40 39 24 63 52 47 23 70
De Ruyck et al.16 101 8 1 9 93 17 0 17
Yu et al.17 64 37 3 40 70 49 2 51
Zienolddiny et al.18 309 26 1 27 368 35 2 37
Matullo et al.19 98 16 2 18 951 141 2 143
Landi et al.20 263 32 1 33 262 53 1 54
Hao et al.21 524 409 91 500 572 459 87 546
zhang et al.22 77 53 19 72 79 68 10 78
Shen et al.23 65 41 12 53 64 40 8 48
Schneider et al.24 389 53 4 57 544 75 3 78
Hung et al.25 1878 259 10 269 1828 292 12 304
Hu et al.26 335 311 64 375 339 308 63 371
Chan et al.27 50 22 3 25 79 67 16 83
Song et al.28 60 44 0 44 61 43 0 43
Chen et al.29 48 44 11 55 57 40 5 45
Ratnasinghe et al.30 52 47 9 56 85 104 21 125
Divine et al.31 300 32 2 34 612 90 2 92
TABLE 1. Baseline Characteristics of the 22 Eligible Studies in the Meta-Analysis
Authors
Ethnicity
(Country) Gender Smoking
Source of
Controls
Sample Size
(Case/Control) Matching Criteria
Yin et al.10 Asian (Chinese) Female Non Hospital 55/74 Age/gender/smoking
Su et al.11 Asian (Chinese) Both Both Population 396/465 NK
Li et al.12 Asian (Chinese) Female Non Hospital 350/350 Age
Improta et al.13 White (Italian) Both NK Hospital 94/121 Age/sex
Yin et al.14 Asian (Chinese) Both Both Hospital 247/253 Age/gender/ethnicity
Pachouri et al.15 Asian (Indian) Both Both Population 103/122 NK
De Ruyck et al.16 White Both Both Hospital 110/110 Age/gender
Yu et al.17 Asian (Chinese) Both Both Population 104/121 Age/gender
Zienolddiny et al.18 White (Norway) Both Both Population 343/413 Age/gender/smoking
Matullo et al.19 Mixed (European) Both Both NK 116/1094 Age/gender/smoking/Country
Landi et al.20 White (European) Both Both Hospital 299/317 Age/gender/center/referral (or residence)
Hao et al.21 Asian (Chinese) Both Both Population 1024/1118 Age/gender/ethnicity
zhang et al.22 Asian (Chinese) Both Both Population 149/157 Age/gender
Shen et al.23 Asian (Chinese) Both Both Population 122/122 Age/gender/village/type of fuel currently used
Schneider et al.24 White (Germany) Both Both Hospital 446/622 NK
Hung et al.25 White (European) Both Both Both 2147/2132 Age/gender/center/referral (or residence) area
Hu et al.26 Asian (Chinese) Both Both Population 710/710 Age/gender/residence
Chan et al.27 Asian (Chinese) Both NK NK 75/162 Age/gender
Song et al.28 Asian (Chinese) Both Both Hospital 104/104 Age/gender
Chen et al.29 Asian (Chinese) Both Both Population 109/109 Age/gender/smoking
Ratnasinghe et al.30 Asian (Chinese) Both Both Population 108/216 Age/gender
David-Beabes and London31 Mixed Both Both Population 334/704 Age/gender/ethnicity
NK, not known.
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male population, and results showed that heterozygote Arg/
Trp variant genotype could decrease lung cancer risk (OR 
0.54, 95% CI  0.31–0.95, p  0.03). Four studies10,12,13,27
reported data on XRCC1 Arg194Trp polymorphism on lung
cancer risk in female population. There were no relationship
between XRCC1 Arg194Trp polymorphism and the risk of
lung cancer in female population with ORs 0.48 (95% CI 
0.07–3.16, p  0.45), 0.97 (95% CI  0.74–1.28, p  0.85),
and 0.99 (95% CI  0.76–1.29, p 0.92) for Trp/Trp versus
Arg/Arg, Arg/Trp versus Arg/Arg, and Trp/Trp  Arg/Trp
versus Arg/Arg, respectively.
There were seven studies10,12,15,22,24,25,31 (three22,24,25
only reported data on Trp/Trp  Arg/Trp and Arg/Arg)
reported XRCC1 Arg194Trp polymorphism on lung cancer
risk in nonsmoking population and five studies15,22,24,25,31
(three22,24,25 only reported data on Trp/Trp  Arg/Trp and
Arg/Arg) in smoking population. The pooled ORs showed
there were no relationship between XRCC1 Arg194Trp poly-
morphism and the risk of lung cancer in both nonsmoking and
smoking population.
XRCC1 Arg194Trp Polymorphism on Lung
Cancer Risk in Specific Types of Carcinoma
The numbers of studies reported XRCC1 Arg194Trp
polymorphism and various histologic types of lung can-
cer were four, four, two, and two for squamous cell
carcinoma15,17,24,25 (one study25 only reported data on Trp/
Trp  Arg/Trp and Arg/Arg), adenocarcinoma12,15,24,25 (one
study25 only reported data on Trp/Trp  Arg/Trp and Arg/
Arg), small cell lung cancer,15,24 and other histologic types of
lung cancer, respectively.15,24 As shown in Table 3, subgroup
analyses did not show XRCC1 Arg194Trp polymorphism
increased the risk of squamous cell carcinoma, adenocarci-
noma, small cell lung cancer, and other histologic types of
lung cancer.
Publication Bias
An extensive search strategy was made to minimize the
potential for publication bias. Publication bias was not found
according to both Begg’s test (0.65, 0.20, and 0.31 for
Trp/Trp versus Arg/Arg, Arg/Trp versus Arg/Arg, and Trp/
Trp  Arg/Trp versus Arg/Arg, respectively) and Egger’s
test (0.56, 0.07, and 0.26 for Trp/Trp versus Arg/Arg, Arg/
Trp versus Arg/Arg, and Trp/Trp  Arg/Trp versus Arg/Arg,
respectively).
DISCUSSION
DNA repair systems play a critical role in protecting the
human genome from damage caused by carcinogens present
in the environment. XRCC1 has an important function in the
base-excision repair pathway. Recent studies have reported
on associations between XRCC1 Arg194Trp polymorphism
and risk of lung cancer, which have given inconsistent results.
FIGURE 1. Meta-analysis in total
population of the 22 studies
showed that homozygous Trp/Trp
variant genotype could increase
lung cancer risk compared with the
homozygous wild Arg/Arg genotype
(odds ratio [OR]  1.22, 95% confi-
dence interval [CI]  1.04–1.44,
p  0.01). Subgroup analyses by
ethnicity confirmed above result in
Asians (OR  1.19, 95% CI  1.01–
1.41, p  0.04) but not in whites.
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Su et al.11 found homozygous Gln/Gln variant genotype
increased risk of lung cancer compared with the homozygous
wild Arg/Arg genotype in Asians. However, De Ruyck et
al.16 found heterozygote Arg/Trp genotype decreased risk of
lung cancer compared with the homozygous wild Arg/Arg
genotype in whites. Yin et al.10 found that the combined
Gln/Gln  Arg/Gln variant genotypes of the Arg194Trp had
a protective effect on the risk of lung cancer in Asians. Chan
et al.27 reported both the heterozygote Arg/Trp and the
combined Gln/Gln  Arg/Gln variant genotypes of the
Arg194Trp had a protective effect on the risk of lung cancer
in Asians. None of the other individual studies showed a
relationship between XRCC1 Arg399Gln polymorphism and
the risk of lung cancer. This diversity motivated the present
meta-analysis. In the total population, we found that homozy-
gous Trp/Trp variant genotype could increase lung cancer
risk compared with the homozygous wild Arg/Arg genotype;
however, heterozygote Arg/Trp variant genotype could de-
crease lung cancer risk. Subgroup analyses by ethnicity
confirmed the result that homozygous Trp/Trp variant geno-
type increased lung cancer risk in Asians but not in whites. It
was interesting to find that both the heterozygote Arg/Trp and
the combined Trp/Trp  Arg/Trp variant genotypes could
decrease the risk of lung cancer in whites but not in Asians.
Our results agreed with the meta-analyses of Wang et al.7
in the heterozygote Arg/Trp and the combined Trp/Trp 
Arg/Trp variant genotypes in total population but not in the
homozygous Trp/Trp variant genotype, which were found
have no association on lung cancer risk in the meta-
analyses of Wang et al. We had added another eight
studies10–13,20,21,23,24 that were not included in the meta-
analyses of Wang et al. and excluded one publication32 in the
meta-analyses of Wang et al., which were found the same
authors reported results obtained from the same patient pop-
ulation in another publication.30
When came into gender, although results in our meta-
analyses showed that heterozygote Arg/Trp variant genotype
could decrease lung cancer risk in male population, there
were only two studies.13,27 One27 displayed both the hetero-
zygote Arg/Trp and the combined Trp/Trp  Arg/Trp variant
genotypes could decrease lung cancer risk in male popula-
tion, and the other one13 did not found an association between
XRCC1 Arg194Trp polymorphism and the risk of lung can-
cer. One10 of the four studies10,12,13,27 found that the com-
bined Gln/Gln  Arg/Gln variant genotypes of the
Arg194Trp had a protective effect on the risk of lung cancer
in female population. However, the pooled ORs in our meta-
analyses showed that the XRCC1 Arg194Trp polymorphism
had no relationship on the risk of lung cancer in female
population. As smoking is an important carcinogenic factor,
there were seven studies,10,12,15,22,24,25,31 and five stud-
ies15,22,24,25,31 reported the data on nonsmoking and smoking
FIGURE 2. Meta-analysis in total
population of the 22 studies
showed that heterozygote Arg/Trp
variant genotype could decrease
lung cancer risk (odds ratio [OR] 
0.91, 95% confidence interval
[CI]  0.85–0.99, p  0.02). Sub-
group analyses by ethnicity con-
firmed above result in whites
(OR  0.83, 95% CI  0.72–0.96,
p  0.01) but not in Asians.
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TABLE 3. Main Results of Pooled ORs in the Meta-Analysis
N Case/Control
Trp/Trp VS Arg/Arg Arg/Trp VS Arg/Arg Trp/TrpArg/Trp VS Arg/Arg
OR (95% CI) p ph OR (95% CI) p ph OR (95% CI) p ph
Total 22 7515/9560 1.22 (1.04–1.44) 0.01 0.11 0.91 (0.85–0.99) 0.02 0.49 0.95 (0.88–1.02) 0.17 0.12
Subanalyses
Ethnicity
Asian 14 3636/4056 1.19 (1.01–1.41) 0.04 0.11 0.96 (0.87–1.05) 0.39 0.59 1.00 (0.91–1.09) 0.97 0.17
White 6 3429/3706 1.43 (0.79–2.59) 0.24 0.32 0.83 (0.72–0.96) 0.01 0.41 0.85 (0.74–0.98) 0.03 0.34
Gender
Male 2 143/196 1.64 (0.05–59.07) 0.79 0.02 0.54 (0.31–0.95) 0.03 0.10 0.92 (0.16–5.25) 0.93 0.01
Female 4 427/511 0.48 (0.07–3.16) 0.45 0.05 0.97 (0.74–1.28) 0.85 0.23 0.99 (0.76–1.29) 0.92 0.11
Smoking
Nonsmoking 7a 674/1724 1.24 (0.26–5.92) 0.79 0.02 1.05 (0.80–1.38) 0.71 0.13 1.04 (0.84–1.29) 0.70 0.18
Smoking 5a 2869/2427 0.67 (0.25–1.78) 0.42 0.98 0.66 (0.43–1.01) 0.06 0.95 0.87 (0.74–1.02) 0.08 0.36
Histology
SCC 4b 1251/2997 1.39 (0.69–2.80) 0.36 0.83 0.84 (0.60–1.17) 0.30 0.95 0.86 (0.71–1.04) 0.11 0.96
AC 4b 830/3226 1.25 (0.70–2.24) 0.44 0.79 1.09 (0.81–1.47) 0.56 0.67 0.96 (0.80–1.21) 0.88 0.52
SCLC 2 78/744 0.91 (0.19–4.31) 0.90 0.21 1.14 (0.60–2.17) 0.70 0.96 1.13 (0.60–2.10) 0.71 0.66
Other 2 94/744 3.78 (0.96–14.92) 0.06 0.70 1.33 (0.73–2.44) 0.36 0.53 1.48 (0.83–2.63) 0.18 0.33
a Three studies only reported data on Trp/Trp  Arg/Trp and Arg/Arg.
b One study only reported data on Trp/Trp  Arg/Trp and Arg/Arg.
SCC, squamous cell carcinoma; AC, adenocarcinoma, SCC, small cell lung cancer; other, other histological types of lung cancer; N, numbers of the studies in each analysis;
ph, p value for heterogeneity test; CI, confidence interval; OR, odds ratio.
FIGURE 3. Meta-analysis in total
population of the 22 studies
showed that the combined Trp/
Trp  Arg/Trp variant genotypes
had no relationship with lung can-
cer risk (odds ratio [OR] OR  0.95,
95% confidence interval [CI] 
0.88–1.02, p  0.17). Subgroup
analyses by ethnicity showed that
the combined Trp/Trp  Arg/Trp
variant genotypes could decrease
lung cancer risk compared with the
homozygous wild Arg/Arg genotype
in whites (OR  0.85, 95% CI 
0.74–0.98, p  0.03) but not in
Asians.
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population. Yin et al.10 found that the combined Gln/Gln 
Arg/Gln variant genotypes of the Arg194Trp had a protective
effect on the risk of lung cancer. None of the other individual
studies showed a relationship between XRCC1 Arg194Trp
polymorphism and lung cancer risk both in nonsmoking
population and in smoking population. The pooled ORs in
our meta-analyses failed to show a relationship between
XRCC1 Arg194Trp polymorphism and lung cancer risk both
in nonsmoking population and in smoking population. As for
specific histologic types of carcinoma, none of the individual
studies showed a relationship between Arg194Trp polymor-
phism and the risk of squamous cell carcinoma, adenocarci-
noma, small cell lung caner, and other histologic types of
lung cancer. In the subgroup analyses, we also failed to find
a relationship between XRCC1 Arg194Trp polymorphism
and the risk of squamous cell carcinoma, adenocarcinoma,
small cell lung cancer, and other histologic types of lung
cancer.
CONCLUSIONS
In summary, our meta-analysis measured the associa-
tion between DNA repair gene XRCC1 Arg194Trp polymor-
phism and lung cancer risk and suggested that homozygous
Trp/Trp variant genotype of XRCC1 Arg194Trp polymor-
phism could increase lung cancer risk in total population,
especially in Asians. However, the heterozygote Arg/Trp
variant genotype might decrease the risk of lung cancer,
especially in whites.
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